ApiJect Holdings, Inc announced that it will receive $162,397,044 in funding on April 15, 2022. The company will issue convertible preferred stock and option, warrant or other right to acquire another security in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.61 USD | +0.55% | -6.25% | -1.71% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.71% | 12.33B | |
+28.79% | 676B | |
+25.50% | 554B | |
-7.64% | 349B | |
+15.00% | 318B | |
+5.99% | 291B | |
+3.49% | 210B | |
-0.27% | 204B | |
-9.65% | 194B | |
-11.71% | 144B |
- Stock Market
- Equities
- RPRX Stock
- News Royalty Pharma plc
- ApiJect Holdings, Inc. announced a financing transaction